{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T08:08:06Z","timestamp":1758960486151},"reference-count":42,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"NIH\/NIAID","award":["1U01AI078073"],"award-info":[{"award-number":["1U01AI078073"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1016\/j.vaccine.2009.10.059","type":"journal-article","created":{"date-parts":[[2010,2,26]],"date-time":"2010-02-26T10:27:47Z","timestamp":1267180067000},"page":"2011-2019","source":"Crossref","is-referenced-by-count":7,"title":["Antigen engineering can play a critical role in the protective immunity elicited by Yersinia pestis DNA vaccines"],"prefix":"10.1016","volume":"28","author":[{"given":"Shixia","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Innocent","family":"Mboudjeka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jon D.","family":"Goguen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"May (Suppl.)","key":"10.1016\/j.vaccine.2009.10.059_bib1","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1093\/infdis\/129.Supplement_1.S13","article-title":"Plague immunization. I. Past and present trends","volume":"129","author":"Meyer","year":"1974","journal-title":"J Infect Dis"},{"issue":"July (1)","key":"10.1016\/j.vaccine.2009.10.059_bib2","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0021-8707(70)90061-4","article-title":"Allergic reactions due to plague vaccine","volume":"46","author":"Reisman","year":"1970","journal-title":"J Allergy"},{"issue":"May (Suppl.)","key":"10.1016\/j.vaccine.2009.10.059_bib3","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1093\/infdis\/129.Supplement_1.S19","article-title":"Plague immunization. II. Relation of adverse clinical reactions to multiple immunizations with killed vaccine","volume":"129","author":"Marshall","year":"1974","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2009.10.059_bib4","first-page":"753","article-title":"Potency of killed plague vaccines prepared from avirulent Yersinia pestis","volume":"58","author":"Williams","year":"1980","journal-title":"Bull World Health Organ"},{"issue":"July (11\u201312)","key":"10.1016\/j.vaccine.2009.10.059_bib5","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/S0264-410X(98)80110-2","article-title":"Protection against experimental bubonic and pneumonic plague by a recombinant capsular F1\u2013V antigen fusion protein vaccine","volume":"16","author":"Heath","year":"1998","journal-title":"Vaccine"},{"issue":"December (3\u20134)","key":"10.1016\/j.vaccine.2009.10.059_bib6","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1574-695X.1995.tb00196.x","article-title":"A new improved sub-unit vaccine for plague: the basis of protection","volume":"12","author":"Williamson","year":"1995","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"July (10)","key":"10.1016\/j.vaccine.2009.10.059_bib7","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/S0264-410X(96)00303-9","article-title":"A sub-unit vaccine elicits IgG in serum, spleen cell cultures and bronchial washings and protects immunized animals against pneumonic plague","volume":"15","author":"Williamson","year":"1997","journal-title":"Vaccine"},{"issue":"October (4\u20135)","key":"10.1016\/j.vaccine.2009.10.059_bib8","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/S0264-410X(00)00159-6","article-title":"A single dose sub-unit vaccine protects against pneumonic plague","volume":"19","author":"Williamson","year":"2000","journal-title":"Vaccine"},{"issue":"August (8)","key":"10.1016\/j.vaccine.2009.10.059_bib9","doi-asserted-by":"crossref","first-page":"5256","DOI":"10.1128\/IAI.73.8.5256-5261.2005","article-title":"Protection against aerosolized Yersinia pestis challenge following homologous and heterologous prime\u2013boost with recombinant plague antigens","volume":"73","author":"Glynn","year":"2005","journal-title":"Infect Immun"},{"issue":"March (16)","key":"10.1016\/j.vaccine.2009.10.059_bib10","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1016\/j.vaccine.2004.10.025","article-title":"Effect of homologous and heterologous prime\u2013boost on the immune response to recombinant plague antigens","volume":"23","author":"Glynn","year":"2005","journal-title":"Vaccine"},{"issue":"August (8)","key":"10.1016\/j.vaccine.2009.10.059_bib11","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1128\/IAI.63.8.2854-2858.1995","article-title":"Active immunization with recombinant V antigen from Yersinia pestis protects mice against plague","volume":"63","author":"Leary","year":"1995","journal-title":"Infect Immun"},{"issue":"September (25\u201326)","key":"10.1016\/j.vaccine.2009.10.059_bib12","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.1016\/S0264-410X(03)00379-7","article-title":"Protective efficacy of a fully recombinant plague vaccine in the guinea pig","volume":"21","author":"Jones","year":"2003","journal-title":"Vaccine"},{"issue":"August (28)","key":"10.1016\/j.vaccine.2009.10.059_bib13","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1016\/S0264-410X(00)00128-6","article-title":"Protection studies following bronchopulmonary and intramuscular immunisation with yersinia pestis F1 and V subunit vaccines coencapsulated in biodegradable microspheres: a comparison of efficacy","volume":"18","author":"Eyles","year":"2000","journal-title":"Vaccine"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2009.10.059_bib14","doi-asserted-by":"crossref","first-page":"3598","DOI":"10.1128\/IAI.73.6.3598-3608.2005","article-title":"Human immune response to a plague vaccine comprising recombinant F1 and V antigens","volume":"73","author":"Williamson","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.10.059_bib15","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1471-2180-5-38","article-title":"Immunization of mice with YscF provides protection from Yersinia pestis infections","volume":"5","author":"Matson","year":"2005","journal-title":"BMC Microbiol"},{"issue":"July (1)","key":"10.1016\/j.vaccine.2009.10.059_bib16","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.pep.2005.02.016","article-title":"Yersinia pestis Yop secretion protein F: purification, characterization, and protective efficacy against bubonic plague","volume":"42","author":"Swietnicki","year":"2005","journal-title":"Protein Expr Purif"},{"issue":"March (13)","key":"10.1016\/j.vaccine.2009.10.059_bib17","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1016\/j.vaccine.2008.01.024","article-title":"Relative immunogenicity and protection potential of candidate Yersinia pestis antigens against lethal mucosal plague challenge in Balb\/C mice","volume":"26","author":"Wang","year":"2008","journal-title":"Vaccine"},{"issue":"July (31)","key":"10.1016\/j.vaccine.2009.10.059_bib18","doi-asserted-by":"crossref","first-page":"3947","DOI":"10.1016\/j.vaccine.2007.12.060","article-title":"Cross-subtype antibody and cellular immune responses induced by a polyvalent DNA prime\u2013protein boost HIV-1 vaccine in healthy human volunteers","volume":"26","author":"Wang","year":"2008","journal-title":"Vaccine"},{"issue":"March (2)","key":"10.1016\/j.vaccine.2009.10.059_bib19","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1586\/14760584.7.2.175","article-title":"Current progress of DNA vaccine studies in humans","volume":"7","author":"Lu","year":"2008","journal-title":"Expert Rev Vaccines"},{"issue":"November\u2013December (6)","key":"10.1016\/j.vaccine.2009.10.059_bib20","doi-asserted-by":"crossref","first-page":"449","DOI":"10.4161\/hv.4.6.6179","article-title":"Immunogenicity of DNA vaccines in humans: it takes two to tango","volume":"4","author":"Lu","year":"2008","journal-title":"Hum Vaccin"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2009.10.059_bib21","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1084\/jem.20071331","article-title":"An HIV-1 clade C DNA prime, NYVAC boost vaccine regimen induces reliable, polyfunctional, and long-lasting T cell responses","volume":"205","author":"Harari","year":"2008","journal-title":"J Exp Med"},{"issue":"February (8)","key":"10.1016\/j.vaccine.2009.10.059_bib22","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.vaccine.2003.09.020","article-title":"Protection against plague afforded by immunisation with DNA vaccines optimised for expression of the Yersinia pestis V antigen","volume":"22","author":"Garmory","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.10.059_bib23","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/0-306-48416-1_84","article-title":"Vaccination with plasmid DNA expressing the Yersinia pestis capsular protein F1 protects mice against plague","volume":"529","author":"Grosfeld","year":"2003","journal-title":"Adv Exp Med Biol"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2009.10.059_bib24","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1128\/IAI.71.1.374-383.2003","article-title":"Effective protective immunity to Yersinia pestis infection conferred by DNA vaccine coding for derivatives of the F1 capsular antigen","volume":"71","author":"Grosfeld","year":"2003","journal-title":"Infect Immun"},{"issue":"September (25\u201326)","key":"10.1016\/j.vaccine.2009.10.059_bib25","doi-asserted-by":"crossref","first-page":"3348","DOI":"10.1016\/j.vaccine.2004.02.036","article-title":"A DNA vaccine producing LcrV antigen in oligomers is effective in protecting mice from lethal mucosal challenge of plague","volume":"22","author":"Wang","year":"2004","journal-title":"Vaccine"},{"issue":"May (21)","key":"10.1016\/j.vaccine.2009.10.059_bib26","doi-asserted-by":"crossref","first-page":"4531","DOI":"10.1016\/j.vaccine.2005.08.023","article-title":"Relative contributions of codon usage, promoter efficiency and leader sequence to the antigen expression and immunogenicity of HIV-1 Env DNA vaccine","volume":"24","author":"Wang","year":"2006","journal-title":"Vaccine"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2009.10.059_bib27","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1128\/JVI.72.2.1497-1503.1998","article-title":"Increased immune response elicited by DNA vaccination with a synthetic gp120 sequence with optimized codon usage","volume":"72","author":"Andre","year":"1998","journal-title":"J Virol"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2009.10.059_bib28","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0960-9822(02)00482-7","article-title":"Codon usage limitation in the expression of HIV-1 envelope glycoprotein","volume":"6","author":"Haas","year":"1996","journal-title":"Curr Biol"},{"issue":"October (10)","key":"10.1016\/j.vaccine.2009.10.059_bib29","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/nrg2432","article-title":"DNA vaccines: ready for prime time?","volume":"9","author":"Kutzler","year":"2008","journal-title":"Nat Rev"},{"issue":"December (23)","key":"10.1016\/j.vaccine.2009.10.059_bib30","doi-asserted-by":"crossref","first-page":"11628","DOI":"10.1128\/JVI.01065-06","article-title":"Hemagglutinin (HA) proteins from H1 and H3 serotypes of influenza A viruses require different antigen designs for the induction of optimal protective antibody responses as studied by codon-optimized HA DNA vaccines","volume":"80","author":"Wang","year":"2006","journal-title":"J Virol"},{"issue":"December (5)","key":"10.1016\/j.vaccine.2009.10.059_bib31","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.vaccine.2004.07.010","article-title":"Plasmid encoding papillomavirus Type 16 (HPV16) DNA constructed with codon optimization improved the immunogenicity against HPV infection","volume":"23","author":"Cheung","year":"2004","journal-title":"Vaccine"},{"issue":"July (31\u201332)","key":"10.1016\/j.vaccine.2009.10.059_bib32","doi-asserted-by":"crossref","first-page":"5872","DOI":"10.1016\/j.vaccine.2006.04.065","article-title":"Passive immunotherapy of Bacillus anthracis pulmonary infection in mice with antisera produced by DNA immunization","volume":"24","author":"Herrmann","year":"2006","journal-title":"Vaccine"},{"issue":"November (7\u20138)","key":"10.1016\/j.vaccine.2009.10.059_bib33","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/S0264-410X(00)00246-2","article-title":"Influence of codon usage on the immunogenicity of a DNA vaccine against tetanus","volume":"19","author":"Stratford","year":"2000","journal-title":"Vaccine"},{"issue":"February (3)","key":"10.1016\/j.vaccine.2009.10.059_bib34","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1128\/JVI.79.3.1906-1910.2005","article-title":"Identification of two neutralizing regions on the severe acute respiratory syndrome coronavirus spike glycoprotein produced from the mammalian expression system","volume":"79","author":"Wang","year":"2005","journal-title":"J Virol"},{"issue":"January (2)","key":"10.1016\/j.vaccine.2009.10.059_bib35","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1089\/aid.1998.14.151","article-title":"Immunogenicity of DNA vaccines expressing human immunodeficiency virus type 1 envelope glycoprotein with and without deletions in the V1\/2 and V3 regions","volume":"14","author":"Lu","year":"1998","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"September (18)","key":"10.1016\/j.vaccine.2009.10.059_bib36","doi-asserted-by":"crossref","first-page":"8392","DOI":"10.1073\/pnas.90.18.8392","article-title":"Production of high-titer helper-free retroviruses by transient transfection","volume":"90","author":"Pear","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2009.10.059_bib37","first-page":"580","article-title":"Factors affecting codon usage in Yersinia pestis","volume":"35","author":"Hou","year":"2003","journal-title":"Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai)"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2009.10.059_bib38","doi-asserted-by":"crossref","first-page":"5731","DOI":"10.1128\/IAI.66.12.5731-5742.1998","article-title":"Complete DNA sequence and detailed analysis of the Yersinia pestis KIM5 plasmid encoding murine toxin and capsular antigen","volume":"66","author":"Lindler","year":"1998","journal-title":"Infect Immun"},{"issue":"April (17)","key":"10.1016\/j.vaccine.2009.10.059_bib39","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1016\/j.vaccine.2008.02.033","article-title":"The relative immunogenicity of DNA vaccines delivered by the intramuscular needle injection, electroporation and gene gun methods","volume":"26","author":"Wang","year":"2008","journal-title":"Vaccine"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2009.10.059_bib40","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1128\/IAI.00950-08","article-title":"The Yersinia pestis caf1M1A1 fimbrial capsule operon promotes transmission by flea bite in a mouse model of bubonic plague","volume":"77","author":"Sebbane","year":"2009","journal-title":"Infect Immun"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2009.10.059_bib41","first-page":"156","article-title":"Pathology of experimental pneumonic plague produced by fraction 1-positive and fraction 1-negative Yersinia pestis in African green monkeys (Cercopithecus aethiops)","volume":"120","author":"Davis","year":"1996","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.vaccine.2009.10.059_bib42","series-title":"Methods in molecular medicine DNA vaccines","first-page":"355","article-title":"Antigen engineering in DNA immunization","author":"Lu","year":"1999"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09015898?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09015898?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,28]],"date-time":"2020-05-28T17:23:56Z","timestamp":1590686636000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X09015898"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":42,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["S0264410X09015898"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.10.059","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,2]]}}}